Literature DB >> 3385212

Biochemical and structural properties of a Hodgkin's disease-related membrane protein.

J F Nawrocki1, E S Kirsten, R I Fisher.   

Abstract

The HeFi-1 mAb recognizes a membrane protein on Hodgkin's disease cells and on a limited number of other human cells that are either tumorigenically transformed or virally activated. Herein biochemical and structural analyses of the HeFi-1 reactive membrane protein (HRMP) were done to identify its potential importance in cellular transformation in the Hodgkin's disease cell line L428, in the T cell lymphoma line HuT 78, and in several EBV-transformed lymphoblastoid cell lines. Immunoprecipitation studies demonstrated that the mature form of the HRMP had an apparent Mr of 120 kDa in tumor cells and 116 kDa in the EBV-transformed cell lines and that it was phosphorylated at both serine and tyrosine residues in all cell lines tested. The precursor to the HRMP is an 86-kDa core protein that, after processing by high mannose N-linked glycosylation, migrates with an apparent Mr of 90 kDa. This protein is then further processed to the mature 120-kDa HRMP in part by O-linked glycosylation, the addition of sialic acid residues, and by the conversion of N-linked oligosaccharides from the high mannose to the complex type. Detectable amounts of the 90-kDa molecule can be found in the membrane and, although this protein can be phosphorylated in vitro, it is not phosphorylated in intact cells. The combined results of this study suggest that the HRMP is involved in cellular metabolism and show that an unusual amount of post-translational processing of the 90-kDa precursor results in the formation, and perhaps phosphorylation, of the mature 120-kDa HRMP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3385212

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene.

Authors:  E J Croager; A M Gout; L J Abraham
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  High expression of the CD30 molecule in human decidual cells.

Authors:  K Ito; T Watanabe; R Horie; M Shiota; S Kawamura; S Mori
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

3.  Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).

Authors:  R Andreesen; W Brugger; G W Löhr; K J Bross
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

4.  Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma.

Authors:  Anneclaire J De Roos; Dana K Mirick; Kerstin L Edlefsen; Andrea Z LaCroix; Kenneth J Kopecky; Margaret M Madeleine; Larry Magpantay; Otoniel Martínez-Maza
Journal:  Cancer Res       Date:  2012-07-30       Impact factor: 12.701

5.  Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer.

Authors:  Parag Parekh; Sanchit Kamble; Nianxi Zhao; Zihua Zeng; Bryce P Portier; Youli Zu
Journal:  Biomaterials       Date:  2013-08-19       Impact factor: 12.479

6.  Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Jimmy Esoinoza; Francesca Gotsch; Samuel Edwin; Tinnakorn Chaiworapongsa; Pooja Mittal; Eleazar Soto; Offer Erez; Shali Mazaki-Tovi; Nandor Gabor Than; Lara A Friel; Bo Hyun Yoon; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-11

7.  Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Sonia S Hassan; Francesca Gotsch; Samuel Edwin; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Shali Mazaki-Tovi; Eleazar Soto; Nandor Gabor Than; Lara A Friel; Bo Hyun Yoon; Jimmy Espinoza
Journal:  J Matern Fetal Neonatal Med       Date:  2007-12

8.  Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells.

Authors:  Peng Zhang; Nianxi Zhao; Zihua Zeng; Yongdong Feng; Ching-Hsuan Tung; Chung-Che Chang; Youli Zu
Journal:  Lab Invest       Date:  2009-10-12       Impact factor: 5.662

9.  IL-2 mRNA expression in Tac-positive malignant lymphomas.

Authors:  M Peuchmaur; D Emilie; M C Crevon; P Solal-Celigny; M C Maillot; G Lemaigre; P Galanaud
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

10.  Cellular localizations and processing of the two molecular forms of the Hodgkin-associated Ki-1 (CD30) antigen. The protein kinase Ki-1/57 occurs in the nucleus.

Authors:  D Rohde; H Hansen; M Hafner; H Lange; V Mielke; M L Hansmann; H Lemke
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.